Creo Medical Group PLC
$0.44
24H
Market Cap
Volume
Supply
Price Chart
About Creo Medical Group PLC - CREO.L
Creo Medical Group PLC is a UK-based company that specializes in the development and commercialization of minimally invasive electrosurgical devices aimed at improving clinical outcomes and streamlining procedures in endoscopy and surgery. Their technology leverages advanced energy in the form of microwave and radiofrequency to aid medical professionals in the targeted treatment of diseases such as cancer.
What are Creo Medical Group PLC's core values and mission statement?
Creo Medical Group PLC's mission is to improve patient outcomes by bringing advanced energy to the field of surgery and therapeutic endoscopy. Their core values focus on innovation, responsibility, and teamwork as they aim to design and deliver transformative medical devices to healthcare professionals.
Who founded Creo Medical Group PLC and when?
Creo Medical Group PLC was founded by Chris Hancock in 2003.
Who leads Creo Medical Group PLC?
As of the last available information, Craig Gulliford was the Chief Executive Officer (CEO) of Creo Medical Group PLC.
Where is Creo Medical Group PLC located, and what is its base country?
Creo Medical Group PLC is located in Chepstow, Monmouthshire, United Kingdom, and its base country is the United Kingdom.
On which exchanges is Creo Medical Group PLC traded?
Creo Medical Group PLC is traded on the London Stock Exchange under the ticker symbol CREO.
Historical data
Creo Medical Group PLC (CREO) Price Live Data
The live price of Creo Medical Group PLC (CREO) is $0.44, with a trading volume of 246,468 in the last 24 hours. Wrapstocks updates the CREO price in real-time. Creo Medical Group PLC is up 0.41% in the last 24 hours. The company has a live market cap of $1,589,848.18 and a supply of 3,614,760 CREO stocks.
Creo Medical Group PLC (CREO) is traded on London Stock Exchange, and currently, the market is closed; trading will be resumed in 10 hours and 11 minutes.
